Cardiovascular Effects of GLP-1 Receptor Agonists Across Age Groups: An Updated Meta-Analysis of Randomized Controlled Trials.
GLP-1 drugs appear to work similarly well for heart protection across different age groups, including people over 75.
This systematic review and meta-analysis evaluated Cardiovascular Effects of GLP-1 Receptor Agonists Across Age Groups: An Updated Meta-Analysis of Randomized Controlled Trials. The abstract reports Among trials reporting three age strata, RHRs showed no clear evidence of effect modification for 65 to < 75 or ≥ 75 years versus < 65 years, but data were available from only four trials, and the ≥ 75-year group was relatively small.
What the study was
- Study design
- Systematic review and meta-analysis
- Population
- Human participants or patients described in the PubMed abstract
- Category
- Public Health
- Maturity
- Validated
- Journal
- Diabetes Obes Metab
Why it surfaced
Systematic review and meta-analysis; PubMed abstract reviewed; synthesis was scored conservatively and no evidence-dependent priority flag was applied.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.